---
schema_version: "secwatch.filing_event.v1"
accession: "0001005286-26-000036"
form_type: "8-K"
ticker: "LFCR"
cik: "0001005286"
company_name: "LIFECORE BIOMEDICAL, INC. DE"
filed_at: "2026-09-29T20:12:15+00:00"
generated_at: "2026-10-12T13:49:26.518100+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.78
calibrated_materiality_score: 0.78
confidence: "high"
source: SEC EDGAR
---

# Lifecore Biomedical unit amends Alcon manufacturing agreement, extends term to Dec. 31, 2034

## Summary
- Lifecore Biomedical, LLC signed Amendment No. 3 with Alcon Research, LLC on Sept. 24, 2026, effective Nov. 1, 2026.
- The amendment extends the Contract Manufacturing Agreement's Initial Term from Dec. 31, 2031 to Dec. 31, 2034, with automatic 24-month renewals.
- It sets Alcon's minimum purchase obligations through 2034 and amends Lifecore's supply obligations under an exhibit.
- From Nov. 1, 2026, Lifecore cannot enter new agreements for products directly competing with certain Alcon products, subject to pre-existing agreement carve-outs.

## SEC filing metadata
- accession: 0001005286-26-000036
- form_type: 8-K
- ticker: LFCR
- cik: 0001005286
- company_name: LIFECORE BIOMEDICAL, INC. DE
- filed_at: 2026-09-29T20:12:15+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.78
- calibrated_materiality_score: 0.78
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1005286/000100528626000036/0001005286-26-000036-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1005286/000100528626000036/lfcr-20260924.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001005286-26-000036
- JSON: https://secwatch.observer/filing/0001005286-26-000036.json
- Plain text: https://secwatch.observer/filing/0001005286-26-000036.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.